Cannabis Science and European Joint Venture Partner Dupetit Sets initial targets on launch of over-the-counter hemp-based Nutraceuticals and Skincare Formulations for the Global Market
12:38 EDT 10 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Cannabis Science (CBIS),
a pioneering U.S. Biotech Company developing pharmaceutical to meet
global public health challenge and over-the-counter cosmetic and
nutraceutical products with their associated acknowledged health
...
Other Sources for this Article
Cannabis Science Inc.
Dr. Robert J. Melamede
President
& CEO
1-888-889-0888
info@cannabisscience.com
www.cannabisscience.com
or
Robert
Kane
VP Investor Relations
1-561-234-6929
rkane@cannabisscience.com
info@cannabisscience.com
www.cannabisscience.com
More From BioPortfolio on "Cannabis Science and European Joint Venture Partner Dupetit Sets initial targets on launch of over-the-counter hemp-based Nutraceuticals and Skincare Formulations for the Global Market"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
